Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China

Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China

Abstract Background Extensively Drug-Resistant (XDR) Tuberculosis (TB) has posed a great threat to global health and finance systems, especially for developing countries with high TB and Multidrug-Resistant (MDR) TB burden. Methods We retrospectively analyzed HIV-uninfected TB case confirmed and tre...

Full description

Bibliographic Details
Main Authors:	Xiao-chun He, Ning-ning Tao, Yao Liu, Xian-xin Zhang, Huai-chen Li
Format:	Article
Language:	English
Published:	BMC 2017-08-01
Series:	BMC Infectious Diseases
Subjects:	XDR-TB Epidemiology trends Treatment outcomes Survival
Online Access:	http://link.springer.com/article/10.1186/s12879-017-2652-x

Similar Items

Prevalence of pre-extensively drug-resistant tuberculosis (Pre XDR-TB) and extensively drug-resistant tuberculosis (XDR-TB) among extra pulmonary (EP) multidrug resistant tuberculosis (MDR-TB) at a tertiary care center in Mumbai in pre Bedaquiline (BDQ) era
by: Ketaki V Utpat, et al.
Published: (2023-01-01)

Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan
by: Yoshiro Murase, et al.
Published: (2010-06-01)

Predominance of Beijing lineage among pre-extensively drug-resistant and extensively drug-resistant strains of Mycobacterium tuberculosis: A tertiary care center experience
by: Syed Beenish Rufai, et al.
Published: (2016-01-01)

Extensively drug resistant tuberculosis in Mali: a case report
by: Bassirou Diarra, et al.
Published: (2017-11-01)

Multidrug- and Extensively Drug-Resistant Tuberculosis, Germany
by: Barbara Eker, et al.
Published: (2008-11-01)

Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis Despite Treatment Adherence, South Africa
by: Alistair D. Calver, et al.
Published: (2010-02-01)

High fluoroquinolone resistance proportions among multidrug-resistant tuberculosis driven by dominant L2 Mycobacterium tuberculosis clones in the Mumbai Metropolitan Region
by: Viola Dreyer, et al.
Published: (2022-08-01)

Co-infection of long-standing extensively drug-resistant Mycobacterium tuberculosis (XDR-TB) and non-tuberculosis mycobacteria: A case report
by: Nafiseh Izadi, et al.
Published: (2015-01-01)

Evaluation of TBMDR® and XDRA® for the detection of multidrug resistant and pre-extensively drug resistant tuberculosis
by: Eunjin Cho, et al.
Published: (2022-05-01)

Mortality and associated factors of patients with extensive drug-resistant tuberculosis: an emerging public health crisis in China
by: Chengli Bei, et al.
Published: (2018-06-01)

Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand
by: Jaksuwan R, et al.
Published: (2017-06-01)

Concise Clinical Review of Hematologic Toxicity of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Role of Mitochondria
by: Amaylia Oehadian, et al.
Published: (2022-04-01)

Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022-01-01)

Trends in multidrug-resistant tuberculosis
by: I. M. F. Dias-Baptista, et al.
Published: (2008-01-01)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
by: Andrey Maryandyshev, et al.
Published: (2017-10-01)

Frequency of first and second-line drug resistance-associated mutations among resistant Mycobacterium tuberculosis clinical isolates from São Paulo, Brazil
by: Tania Matsui, et al.
Published: (2020-05-01)

High clustering rate and genotypic drug-susceptibility screening for the newly recommended anti-tuberculosis drugs among global extensively drug-resistant Mycobacterium tuberculosis isolates
by: Kanwara Trisakul, et al.
Published: (2022-12-01)

Tailored treatment for tuberculosis in transgender individuals: a call for a patient-centered approach from a large Italian cohort
by: Niccolò Riccardi, et al.
Published: (2024-01-01)

Genomic diversity of drug-resistant Mycobacterium tuberculosis isolates in Lisbon Portugal: Towards tuberculosis genomic epidemiology
by: João Perdigão, et al.
Published: (2015-01-01)

Prevalence of resistance to second-line tuberculosis drug among multidrug-resistant tuberculosis patients in Viet Nam, 2011
by: Hoa Binh Nguyen, et al.
Published: (2016-06-01)

Turning the tide against tuberculosis
by: Nesri Padayatchi, et al.
Published: (2017-03-01)

THE ROLE OF THE IMPLANTABLE PORT SYSTEM FOR THE CENTRAL VENOUS ACCESS IN TREATMENT OF PULMONARY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVELY DRUG RESISTANCE (PRELIMINARY RESULTS)
by: О.R. RAZAKOV, et al.
Published: (2018-08-01)

Treatment Outcomes of Extensively Drug-Resistant Tuberculosis in Pakistan: A Countrywide Retrospective Record Review
by: Muhammad Abubakar, et al.
Published: (2021-03-01)

Early culture conversion and cure for extensively drug-resistant tuberculosis is possible with appropriate treatment: lessons learnt from a case study in South Africa
by: Karen Shean, et al.
Published: (2015-11-01)

Spread of Extensively Drug-resistant Tuberculosis
by: Sofía Samper, et al.
Published: (2007-04-01)

Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing
by: Jun Chen, et al.
Published: (2017-04-01)

Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients
by: S. E. J. van de Berg, et al.
Published: (2021-07-01)

Preliminary Favorable Outcome for Medically and Surgically Managed Extensively Drug-Resistant Tuberculosis, France, 2009–2014
by: Benoît Henry, et al.
Published: (2016-03-01)

Extensively drug-resistant tuberculosis: a case report and literature review
by: João Alves de Araújo-Filho, et al.

Drug resistance pattern of M. tuberculosis in category II treatment failure pulmonary tuberculosis patients
by: Fahmida Rahman, et al.
Published: (2013-01-01)

Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France
by: Isabelle Bonnet, et al.
Published: (2022-06-01)

Extensively Drug-Resistant Tuberculosis, Pakistan
by: Rumina Hasan, et al.
Published: (2010-09-01)

Tackling Drug-Resistant Tuberculosis: New Challenges from the Old Pathogen <i>Mycobacterium tuberculosis</i>
by: Giuseppe Mancuso, et al.
Published: (2023-09-01)

Computational analysis of RNA methyltransferase Rv3366 as a potential drug target for combating drug-resistant Mycobacterium tuberculosis
by: Tasmin Nazim, et al.
Published: (2024-01-01)

Multidrug and extensively drug-resistant tuberculosis management: Evidences and controversies
by: R Prasad
Published: (2012-01-01)

Challenge to treat pre-extensively drug-resistant tuberculosis in a low-income country: A report of 12 cases
by: Innocent Murhula Kashongwe, et al.
Published: (2020-12-01)

Drug-Resistant Tuberculosis, KwaZulu-Natal, South Africa, 2001–2007
by: Kristina Wallengren, et al.
Published: (2011-10-01)

Overview of drug-resistant tuberculosis worldwide
by: Ali A Velayati, et al.
Published: (2016-01-01)

Do we need a new Fleming époque: The nightmare of drug-resistant tuberculosis
by: Giovanni Sotgiu, et al.
Published: (2013-01-01)

Drug resistance patterns, treatment outcomes and factors affecting unfavourable treatment outcomes among extensively drug resistant tuberculosis patients in Pakistan; a multicentre record review
by: Muhammad Atif, et al.
Published: (2022-04-01)